# Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)

> **NCT02395757** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 182 (actual)

## Conditions studied

- Stage 3 Age Related Macular Degeneration (AREDS Classification)

## Interventions

- **DEVICE:** MAIA™ (Centervue, Padova, Italy; distributed in France by EDC Lamy, Carvin, France)

## Key facts

- **NCT ID:** NCT02395757
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-09
- **Final completion:** 2020-01-08
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02395757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02395757, "Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02395757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*